{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T19:42:35Z","timestamp":1787686955611,"version":"build-2784847793"},"reference-count":34,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,12,15]],"date-time":"2016-12-15T00:00:00Z","timestamp":1481760000000},"content-version":"vor","delay-in-days":1140,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","hpbonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HPB"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1111\/hpb.12047","type":"journal-article","created":{"date-parts":[[2013,1,18]],"date-time":"2013-01-18T06:53:25Z","timestamp":1358492005000},"page":"858-864","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Sinusoidal obstruction syndrome (SOS) related to chemotherapy for colorectal liver metastases: factors predictive of severe SOS lesions and protective effect of bevacizumab"],"prefix":"10.1016","volume":"15","author":[{"given":"Catherine","family":"Hubert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Sempoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Humblet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"van den Eynde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Zech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Leclercq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Gigot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/hpb.12047_bb0010","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/bjs.5764","article-title":"Colorectal cancer with synchronous liver metastases","volume":"94","author":"Adam","year":"2007","journal-title":"Br J Surg"},{"key":"10.1111\/hpb.12047_bb0015","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.ejca.2007.07.017","article-title":"Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group","volume":"43","author":"Nordlinger","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1111\/hpb.12047_bb0020","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0140-6736(08)60455-9","article-title":"Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomized controlled trial","volume":"371","author":"Nordlinger","year":"2008","journal-title":"Lancet"},{"key":"10.1111\/hpb.12047_bb0025","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1002\/cncr.23099","article-title":"Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases","volume":"110","author":"Ribero","year":"2007","journal-title":"Cancer"},{"key":"10.1111\/hpb.12047_bb0030","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.ejca.2006.04.012","article-title":"Towards a pan-European consensus on the treatment of patients with colorectal liver metastases","volume":"42","author":"Van","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1111\/hpb.12047_bb0035","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1471-2407-8-120","article-title":"Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases","volume":"8","author":"Gruenberger","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1111\/hpb.12047_bb0040","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1097\/01.sla.0000145964.08365.01","article-title":"Tumour progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?","volume":"240","author":"Adam","year":"2004","journal-title":"Ann Surg"},{"key":"10.1111\/hpb.12047_bb0045","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/annonc\/mdh095","article-title":"Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer","volume":"15","author":"Rubbia-Brandt","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1111\/hpb.12047_bb0050","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1478-3231.2007.01511.x","article-title":"Nodular regenerative hyperplasia: a deleterious consequence of chemotherapy for colorectal liver metastases?","volume":"27","author":"Hubert","year":"2007","journal-title":"Liver Int"},{"key":"10.1111\/hpb.12047_bb0055","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.surg.2009.01.004","article-title":"Prevalence and clinical relevance of pathological hepatic changes occurring after neoadjuvant chemotherapy for colorectal liver metastases","volume":"147","author":"Hubert","year":"2010","journal-title":"Surgery"},{"key":"10.1111\/hpb.12047_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.sla.0000193603.26265.c3","article-title":"Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases","volume":"243","author":"Karoui","year":"2006","journal-title":"Ann Surg"},{"key":"10.1111\/hpb.12047_bb0065","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/SLA.0b013e31815774de","article-title":"Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy","volume":"247","author":"Nakano","year":"2008","journal-title":"Ann Surg"},{"key":"10.1111\/hpb.12047_bb0070","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1200\/JCO.2005.05.3074","article-title":"Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases","volume":"24","author":"Vauthey","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1111\/hpb.12047_bb0075","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S1470-2045(09)70064-6","article-title":"Management of chemotherapy-associated hepatotoxicity in colorectal liver metastases","volume":"10","author":"Chun","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1111\/hpb.12047_bb0080","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/bjs.5719","article-title":"Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases","volume":"94","author":"Zorzi","year":"2007","journal-title":"Br J Surg"},{"key":"10.1111\/hpb.12047_bb0085","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1245\/s10434-010-1385-5","article-title":"Regenerative nodular hyperplasia of the liver related to chemotherapy: impact on outcome of liver surgery for colorectal metastases","volume":"18","author":"Wicherts","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1111\/hpb.12047_bb0090","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.2214\/ajr.157.6.1950868","article-title":"CT of acquired abnormalities of the spleen","volume":"157","author":"Taylor","year":"1991","journal-title":"AJR Am J Roentgenol"},{"key":"10.1111\/hpb.12047_bb0095","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0002-9610(92)90400-L","article-title":"Indocyanine green clearance as a predictor of successful hepatic resection in cirrhotic patients","volume":"163","author":"Hemming","year":"1992","journal-title":"Am J Surg"},{"key":"10.1111\/hpb.12047_bb0100","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1001\/jama.1967.03120160102016","article-title":"Indocyanine green clearance as a test for hepatic function. Evaluation by dichromatic ear densitometry","volume":"200","author":"Leevy","year":"1967","journal-title":"JAMA"},{"key":"10.1111\/hpb.12047_bb0105","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hep.21520","article-title":"FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C","volume":"45","author":"Koda","year":"2007","journal-title":"Hepatology"},{"key":"10.1111\/hpb.12047_bb0110","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.21669","article-title":"FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest","volume":"46","author":"Vallet-Pichard","year":"2007","journal-title":"Hepatology"},{"key":"10.1111\/hpb.12047_bb0115","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple non-invasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"10.1111\/hpb.12047_bb0120","doi-asserted-by":"crossref","first-page":"592","DOI":"10.2307\/2528498","article-title":"A scaling procedure for ordered categorical data","volume":"20","author":"Snell","year":"1964","journal-title":"Biometrics"},{"key":"10.1111\/hpb.12047_bb0125","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1200\/JCO.2006.05.8156","article-title":"Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases","volume":"24","author":"Aloia","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1111\/hpb.12047_bb0130","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.ejso.2007.09.007","article-title":"Effect of preoperative chemotherapy on liver resection for colorectal liver metastases","volume":"34","author":"Mehta","year":"2008","journal-title":"Eur J Surg Oncol"},{"key":"10.1111\/hpb.12047_bb0135","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/SLA.0b013e3181c79403","article-title":"Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatin-based chemotherapy for colorectal liver metastases: correlation with post-hepatectomy outcome","volume":"251","author":"Soubrane","year":"2010","journal-title":"Ann Surg"},{"key":"10.1111\/hpb.12047_bb0140","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/SLA.0b013e31815f6e5b","article-title":"Preoperative portal vein embolization for major liver resection: a meta-analysis","volume":"247","author":"Abulkhir","year":"2008","journal-title":"Ann Surg"},{"key":"10.1111\/hpb.12047_bb0145","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/01.SLA.0000065265.16728.C0","article-title":"Preoperative portal vein embolization for extended hepatectomy","volume":"237","author":"Hemming","year":"2003","journal-title":"Ann Surg"},{"key":"10.1111\/hpb.12047_bb0150","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1365-2559.2010.03511.x","article-title":"Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis","volume":"56","author":"Rubbia-Brandt","year":"2010","journal-title":"Histopathology"},{"key":"10.1111\/hpb.12047_bb0155","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1200\/JCO.2009.27.5701","article-title":"Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury","volume":"28","author":"Overman","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1111\/hpb.12047_bb0160","doi-asserted-by":"crossref","first-page":"5254","DOI":"10.1200\/JCO.2008.17.7857","article-title":"Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases","volume":"26","author":"Kesmodel","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1111\/hpb.12047_bb0165","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1245\/s10434-006-9074-0","article-title":"Lack of evidence for increased operative morbidity after hepatectomy with perioperative use of bevacizumab: a matched case\u2013control study","volume":"14","author":"D'Angelica","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1111\/hpb.12047_bb0170","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jamcollsurg.2007.06.290","article-title":"Addition of bevacizumab to irinotecan- and oxaliplatin-based preoperative chemotherapy regimens does not increase morbidity after resection of colorectal liver metastases","volume":"206","author":"Reddy","year":"2008","journal-title":"J Am Coll Surg"},{"key":"10.1111\/hpb.12047_bb0175","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ejso.2008.12.013","article-title":"Bevacizumab protects against sinusoidal obstruction syndrome and does not increase response rate in neoadjuvant XELOX\/FOLFOX therapy of colorectal cancer liver metastases","volume":"35","author":"Klinger","year":"2009","journal-title":"Eur J Surg Oncol"}],"container-title":["HPB"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X15313381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X15313381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T23:58:56Z","timestamp":1761263936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1365182X15313381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S1365182X15313381"],"URL":"https:\/\/doi.org\/10.1111\/hpb.12047","relation":{},"ISSN":["1365-182X"],"issn-type":[{"value":"1365-182X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sinusoidal obstruction syndrome (SOS) related to chemotherapy for colorectal liver metastases: factors predictive of severe SOS lesions and protective effect of bevacizumab","name":"articletitle","label":"Article Title"},{"value":"HPB","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/hpb.12047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 International Hepato-Pancreato-Biliary Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}